---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-014841"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:52:06.131871+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# FOXO Technologies majority stockholder approves authorized share increase from 10B to 25B

## Summary
- Majority stockholder (Rennova Health, Inc., controlled by CEO) holding 97.59% voting rights approved via written consent on March 27, 2026.
- Amendment increases authorized Class A Common Stock from 10,000,000,000 to 25,000,000,000 shares.
- Effective date will be 20 days after mailing of definitive Information Statement; preliminary 14C filed April 1, 2026.
- Board has discretion to set effective date without further stockholder approval.
- Record date for consent was March 20, 2026.

## SEC filing metadata
- accession: 0001493152-26-014841
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000149315226014841/0001493152-26-014841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000149315226014841/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-014841
- JSON: https://secwatch.observer/filing/0001493152-26-014841.json
- Plain text: https://secwatch.observer/filing/0001493152-26-014841.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.